
| Pair Name | Dihydroartemisinin, Capecitabine | ||
| Phytochemical Name | Dihydroartemisinin (PubChem CID: 3000518 ) | ||
| Anticancer drug Name | Capecitabine (PubChem CID: 60953 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Dihydroartemisinin, Capecitabine | |||
| Disease Info | [ICD-11: 2B91.Z] | Colorectal cancer | Investigative | |
| Gene Regulation | Down-regulation | Expression | CTNNB1 | hsa1499 |
| Down-regulation | Expression | TCF7 | hsa6932 | |
| Down-regulation | Expression | MMP9 | hsa4318 | |
| Down-regulation | Expression | GSK3B | hsa2932 | |
| Down-regulation | Expression | MKI67 | hsa4288 | |
| Down-regulation | Expression | PECAM1 | hsa5175 | |
| In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
| DLD-1 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0248 | |
| HCT 15 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0292 | |
| SW620 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0547 | |
| CT26 | Mouse colon adenocarcinoma | Mus musculus (Mouse) | CVCL_7254 | |
| In Vivo Model | CT26 cells (8×10⁵) were injected into the tail vein of BALB/c mice to establish the lung metastasis model. HCT116 cells (2×106) were injected into the tail vein of BALB/c nude mice to establish the peritoneal metastasis model. | |||
| Result | DHA in combination with Cap could be a novel therapeutic strategy for CRC with improved efficacy and reduced side effects. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine. Cancer Lett. 2024 Feb 1;582:216596. doi: 10.1016/j.canlet.2023.216596. | Click |